Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

TRIL $14.65 0.6000 +4.27%
IMMU $2.22 0.0900 +4.23%
CLVS $31.39 0.9900 +3.26%
ARRY $6.23 0.1600 +2.64%
GERN $2.11 0.0400 +1.93%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

OHRP $3.10 -0.3000 -8.82%
FBIO $2.45 -0.1600 -6.13%
IDRA $1.83 -0.1000 -5.18%
CASC $1.17 -0.0600 -4.88%
AGEN $5.16 -0.2600 -4.80%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next > | Last >>

Urge Congress to Support Federal Research Funding in FY 2017

(ASCO in Action) Oct 13, 2016 - In advance of the ‘lame duck’ session scheduled after the November election, ASCO is continuing its outreach to Congress to urge lawmakers to include a funding increase for the National Institutes of Health (NIH) in the FY 2017 spending bill.
read article 

Novocure Enrolls First Patient In Phase 3 Pivotal Brain Metastases Trial

(TheStreet) Oct 12, 2016 - METIS phase 3 pivotal trial will study radiosurgery plus Tumor Treating Fields compared to radiosurgery alone for brain metastases from non-small cell lung cancer.
read article 

Research on Common Bacterium Opens Door to Fighting Gastric Cancer

(University of Georgia/UGA News) Oct 11, 2016 - A common bacterium that more than half of people have in their gut can use hydrogen gas present in the gastrointestinal tract to inject a cancer-causing toxin into otherwise healthy cells, according to a recently published study led by University of Georgia researchers.
read article 

Faulty Molecule Offers New Target for Treating Liver Cancer

(ICR [UK]) Oct 13, 2016 - Blocking a single faulty molecule in a biological process that drives the growth of advanced liver cancers could offer a new way to treat the disease, researchers have found.
read article 

New Findings Challenge Current View of How Pancreatic Cancer Develops

(OICR News [Canada]) Oct 12, 2016 - Researchers in the multidisciplinary PanCuRx research initiative at the Ontario Institute for Cancer Research and University Health Network’s Princess Margaret Cancer Centre, led by Dr. Faiyaz Notta and Dr. Steven Gallinger, today published new findings that challenge current beliefs about how and why pancreatic cancer is so aggressive.
read press release 

Freeze Therapy: An Alternative To Breast Cancer Surgery?

(St. Louis Post-Dispatch/HealthDay News) Oct 12, 2016 - A freezing technique known as cryoablation might be a viable alternative to lumpectomy for treating small, early stage breast cancers, researchers report.
read article 

Common Prostate Cancer Treatment Linked to Later Dementia, Researcher Says

(Stanford Medicine) Oct 13, 2016 - A new retrospective study of patient medical records suggests that men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as prostate cancer patients whose testosterone levels are not tampered with.
read press release 

ASCO Issues New Guideline for Global Cervical Cancer Screening

(Medscape Medical News) Oct 12, 2016 - A new global guideline on screening for cervical cancer, which provides evidence-based recommendations for screening, follow-up, and treatment for high-risk lesions, has been released by the American Society of Clinical Oncology (ASCO).
read article (free registration required) 

New Report Questions Value of Mammograms

(NBC News) Oct 12, 2016 - A new report questioning the value of routine mammograms has generated an unusual amount of almost angry criticism from experts who say it will confuse women without adding any value to the debate.
read article 

Study Questions Value of Mammograms, Breast Cancer Screening

(CBS News/Associated Press) Oct 12, 2016 - A new study questions the value of mammograms for breast cancer screening. It concludes that a woman is more likely to be diagnosed with a small tumor that is not destined to grow than she is to have a true problem spotted early.
read article 

ASCO Issues Global Recommendations to Increase Cervical Cancer Screening

(ASCO) Oct 12, 2016 - The American Society of Clinical Oncology (ASCO) today issued a new global guideline on screening for cervical cancer, one of the leading causes of cancer related death among women worldwide.
read press release 

OncoGenex Announces Results From the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer

(OncoGenex) Oct 13, 2016 - OncoGenex Pharmaceuticals, Inc. announced today results from the final analysis of the Phase 3 ENSPIRIT trial of custirsen in patients whose non-small cell lung cancer (NSCLC) has progressed following initial treatments.
read corporate press release 

Clinical Takeaways From the ESMO Presidential Symposia

(Medscape Oncology/Commentary) Oct 10, 2016 - ESMO promised practice-changing clinical trials at their annual congress this year, and the final program delivered, particularly in lung cancer.
read article (free registration required) 

Tax Soda To Fight Obesity, WHO Urges Nations Around The Globe

(NPR/The Salt blog) Oct 11, 2016 - The World Health Organization has already urged us to cut back on sugar, limiting added sugars to no more than 10 percent of our daily calories.
read article 

St. Jude Warns Defibrillator Patients About Battery Risks

(Bloomberg) Oct 11, 2016 - St. Jude Medical Inc. is warning patients that the batteries on thousands of its implantable defibrillators can quickly and unexpectedly deplete, in rare cases leaving them vulnerable should they need a shock from the device to restart their faltering hearts.
read article 

What Experimental Drug? Most Companies Don’t Post Compassionate Use Policies

(STAT/Pharmalot) Oct 11, 2016 - As patients clamor for greater access to experimental medicines, a survey released Tuesday finds that just 19 percent of 100 drug makers publicly post policies about their programs for obtaining these drugs, which are known as compassionate use.
read article 

House Dem to Introduce Sweeping Drug Pricing Bill

(The Hill) Oct 11, 2016 - Rep. Rose DeLauro (D-Conn.) is introducing a new measure to fight back against rising drug prices, an issue that has faced a growing uproar.
read article 

Inova Schar Cancer Institute Partners with N-of-One to Support the Launch of Inova’s Molecular Tumor Board

(Biotech 365) Oct 12, 2016 - N-of-One’s clinical interpretation and clinical trial matching provides patient-specific treatment strategies to empower Inova’s precision medicine program.
read article 

UV Light Robots Cut C. Diff Transmissions by 25 Percent on Cancer Patient Floors, Penn Study Finds

(Penn Medicine) Oct 6, 2016 - Newly published research from Penn Medicine infection control specialists found that ultraviolet (UV) robots helped reduce the rates of transmission of the common bacterial infection known as Clostridium difficile (C. diff) among cancer inpatients – mostly blood cancer patients, a group more vulnerable to hospital-acquired infections – by 25 percent.
read press release 

Annual UK Cancer Cases Set to Soar to Half a Million in Less Than 20 Years

(Cancer Research UK) Oct 12, 2016 - Five hundred thousand people will be diagnosed with cancer each year in the UK by 2035 if trends continue, according to a Cancer Research UK study published in the British Journal of Cancer.
read press release 

ICLIO Conference: Top-Level Takeaways

(ACCCBuzz) Oct 12, 2016 - The Institute for Clinical Immuno-Oncology (ICLIO) National Conference on September 30 in Philadelphia provided a window into the real-world immuno-oncology (I-O) issues facing providers, patients, and payers.
read article 

New Special Series in the Journal of Oncology Practice Highlights ASCO’s 2016 Quality Care Symposium

(ASCO in Action) Oct 11, 2016 - The October print issue of the Journal of Oncology Practice (JOP) is a Special Series on ASCO’s 2016 Quality Care Symposium (QCS). The issue features research and highlights from the meeting that brought together top leaders in the field to share strategies and methods for measuring and improving the quality and safety of cancer care.
read article 

Gamida Cell Receives FDA Breakthrough Therapy Designation For NiCord®

( Oct 11, 2016 - NiCord is a novel graft modality for bone marrow transplantation in patients with hematological malignancies including leukemia and lymphoma.
read article 

Syros Announces Approval of Investigational Device Exemption (IDE) for Blood Test to Identify Cancer Patients with Proprietary Biomarkers

(4-traders) Oct 11, 2016 - IDE allows Syros to expand ongoing phase 2 clinical trial of SY-1425 into newly diagnosed acute myeloid leukemia and low-risk myelodysplastic syndrome patients.
read article 

Celgene and Agios Announce Collaborations with Abbott for Diagnostic Identification of IDH Mutations in AML

(NASDAQ) Oct 12, 2016 - Companion diagnostic technology to be utilized with enasidenib (AG-221/CC-90007) and AG-120 development programs for relapsed/refractory acute myeloid leukemia (AML); approximately 20% of AML patients have an IDH mutation.
read article